Acumen Pharmaceuticals pays off K2 HealthVentures loan, cuts 52 jobsNov 5RestructuringAcumen Pharmaceuticals
Acumen's sabirnetug fails Phase 2 Alzheimer's trial, company halts developmentOct 30Clinical readoutAcumen Pharmaceuticals
Acumen reiterates November 2026 ALTITUDE-AD readout for Alzheimer's drug sabirnetugOct 26Quarterly updateAcumen Pharmaceuticals
Acumen reports Q2 2026 results, reaffirms ALTITUDE-AD readout for late 2026Aug 12Quarterly updateAcumen Pharmaceuticals